AR status was available for 15/18 patients; positive tumour staining for AR was seen in 12/15 cases, and all but one of these had received prior AR-directed treatment with bicalutamide with or without a luteinising hormone-releasing hormone (LHRH) agonist. This evidence concerns the gene GNRH1 and neoplasm.